Fakultni Nemocnice V Motole
Fakultni Nemocnice V Motole is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
ANtibiotic TReatment OPtimisation – randomised controlled trial of Clostridioides difficile infection therapy (ANTROP-I)
Sponsor Fakultni Nemocnice Bulovka
- Start (EU)
- Latest update
- Estimated end
- Not reported
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 - A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group - IntReALL BCP 2020
Sponsor Charite Universitaetsmedizin Berlin KöR
- Start (EU)
- Not reported
- Latest update
- Estimated end
AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia
Sponsor Universitaetsklinikum Schleswig-Holstein
- Start (EU)
- Latest update
- Estimated end
A Randomized Placebo controlled Phase I/II Study Evaluating the Safety and Efficacy of Alpha1H in adult patients with non-muscle invasive bladder cancer awaiting transurethral surgery
Sponsor Hamlet BioPharma AB
- Start (EU)
- Latest update
- Estimated end
- Not reported
Questions about this trial experience
What services are recorded for Fakultni Nemocnice V Motole?
The 2026-10-09 snapshot links Fakultni Nemocnice V Motole to 4 distinct CTIS trials. Recorded services include Clinical monitoring, Data management, Investigator recruitment, Laboratory services, among 9 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Fakultni Nemocnice V Motole?
The most frequently recorded therapeutic areas are Gastroenterology, Haematological Malignancies, Infectious Disease. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Fakultni Nemocnice V Motole conducted?
The linked trials record locations in 13 countries, including Czechia, Austria, Germany, Italy, Denmark. These are trial locations, not confirmed office locations or countries where Fakultni Nemocnice V Motole delivered services.
What can this page tell me about Fakultni Nemocnice V Motole's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Fakultni Nemocnice V Motole. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Fakultni Nemocnice V Motole